Prograf, Tacrolimus Newswire

Prograf, Tacrolimus Newswire

Comprehensive Real-Time News Feed for Prograf, Tacrolimus (generic).

Results 1 - 9 of 9 in Prograf, Tacrolimus (generic)

  1. Kidney Transplant Market 2020 US Analysis, Company Profiles,...Read the original story w/Photo

    Tuesday Jun 13 | SBWire

    "Kidney Transplant Market, Numbers & Forecast for United States, Mexico & Canada" explores a comprehensive assessment of the fast-evolving, high growth Kidney Transplant Market. This 53 page report with 33 Figures & 1 Table provides the number of kidney transplant, as well as market and market shares of Kidney Transplant Market.

    Comment?

  2. Long-term follow-up of a phase III clinical trial comparing...Read the original story

    Monday Jun 12 | CiteULike

    Long-term follow-up of a phase III clinical trial comparing tacrolimus extended-release/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. In a phase III, open-label, comparative, noninferiority study, 638 subjects receiving de novo kidney transplants were randomized to one of three treatment arms: tacrolimus extended-release qd, tacrolimus bid, or cyclosporine bid.

    Comment?

  3. Extended-release tacrolimus: a review of its use in de novo kidney transplantation.Read the original story

    Monday Jun 12 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Extended-release tacrolimus [Advagraf ; Astagraf XL ; Graceptor ; Prograf XL ] is a once-daily formulation of the immunosuppressive calcineurin inhibitor, which is approved in many countries worldwide for the prophylaxis of transplant rejection in adult de novo kidney transplant recipients.

    Comment?

  4. Intravenous Immunoglobulin (Ivig) Market Is Expected To Grow At...Read the original story w/Photo

    Thursday Jun 8 | World News Report

    Global Intravenous Immunoglobulin Market information, by type , by Appliaction - Forecast to 2023 Key Players are ABEONA THERAPEUTICS , Baxter , BDI Pharma , Biotest AG. ,, China Biologic Products, Inc. , CSL Behring , Grifols Inc. , " The global market for Intravenous Immunoglobulin market is growing continuously and expected to grow at a CAGR of 5.9% from 2016 to 2023.

    Comment?

  5. Astellas Reports Full Year FY2016 Financial ResultsRead the original story

    Apr 26, 2017 | Customer Interaction Solutions

    Astellas Pharma Inc. today announced the financial results for fiscal year 2016 ended March 31, 2017. "We achieved multiple milestones including the acquisition of Ganymed last December and an agreement with Ogeda shareholders to acquire Ogeda last month.

    Comment?

  6. Astellas Reports the First Nine Months Financial Results of FY2016Read the original story

    Jan 30, 2017 | Customer Interaction Solutions

    Astellas Pharma Inc. today announced financial results for three quarters of fiscal year 2016 ending March 31, 2017 . "We achieved many milestones including the acquisition of Ganymed Pharmaceuticals, a Germany-based pharma company, last December.

    Comment?

  7. Drug names need to be simplified for our patients' safetyRead the original story

    Nov 29, 2016 | Kevin, M.D.

    The patient's heart was beating dangerously slowly, and his EKG showed third-degree AV block: His heart's electrical system had completely shut down in the middle. If this were TV, the doctors would have started shouting "Epi!" and "Get the pads!" immediately.

    Comment?

  8. Astellas Reports First Half FY2016 Financial Results, Revises Fiscal Year OutlookRead the original story

    Oct 27, 2016 | Customer Interaction Solutions

    Astellas Pharma Inc. today announced financial results for the first six months of fiscal year 2016 ending March 31, 2017 . "Our results continue to demonstrate sustainable growth by increasing sales of key global products, XTANDI and Betanis / Myrbetriq / BETMIGA , launching new products and investment for innovation," said Yoshihiko Hatanaka, President and CEO, Astellas.

    Comment?

  9. Kidney Transplant Market by Country Analysis and Forecast to 2021; New Report LaunchedRead the original story w/Photo

    Oct 20, 2016 | SBWire

    Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease patients.

    Comment?